Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — March 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Tarsus Pharmaceuticals, Inc. (TARS)

Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Mar 19, 2026
Sale
Shares
2,186
Price
$67.00
Total Value
$146.46K
Shares Held After
43,316
% of Holdings
4.8%

Tarsus Pharmaceuticals, Inc. (TARS)

Neervannan Seshadri — Chief Operating Officer
Mar 19, 2026
Sale
Shares
4,589
Price
$67.00
Total Value
$307.46K
Shares Held After
85,780
% of Holdings
5.1%

Tarsus Pharmaceuticals, Inc. (TARS)

Lin Elizabeth Yeu — Chief Medical Officer
Mar 19, 2026
Sale
Shares
390
Price
$67.00
Total Value
$26.13K
Shares Held After
23,308
% of Holdings
1.6%

Tarsus Pharmaceuticals, Inc. (TARS)

Whitfield Dianne C. — Chief Human Resources Officer
Mar 19, 2026
Sale
Shares
4,174
Price
$67.00
Total Value
$279.66K
Shares Held After
35,028
% of Holdings
10.6%

Tarsus Pharmaceuticals, Inc. (TARS)

Mottiwala Aziz — Chief Commercial Officer
Mar 19, 2026
Sale
Shares
4,440
Price
$67.00
Total Value
$297.48K
Shares Held After
61,480
% of Holdings
6.7%

Tarsus Pharmaceuticals, Inc. (TARS)

Wahl Bryan — General Counsel
Mar 19, 2026
Sale
Shares
4,231
Price
$67.00
Total Value
$283.48K
Shares Held After
63,959
% of Holdings
6.2%

Alignment Healthcare, Inc. (ALHC)

Wagner Andreas P. — Chief Human Resources Officer
Mar 19, 2026
Sale
Shares
11,602
Price
$18.22
Total Value
$211.40K
Shares Held After
148,628
% of Holdings
7.2%

PROCEPT BioRobotics Corp (PRCT)

Nouri Alaleh — EVP, CLO, CORP. SEC.
Mar 19, 2026
Sale
Shares
2,332
Price
$26.15
Total Value
$60.97K
Shares Held After
105,354
% of Holdings
2.2%

PROCEPT BioRobotics Corp (PRCT)

Nouri Alaleh — EVP, CLO, CORP. SEC.
Mar 19, 2026
Sale
Shares
3,031
Price
$25.82
Total Value
$78.26K
Shares Held After
107,686
% of Holdings
2.7%

Stoke Therapeutics, Inc. (STOK)

Ticho Barry — CHIEF MEDICAL OFFICER
Mar 19, 2026
Sale
Shares
1,461
Price
$29.99
Total Value
$43.82K
Shares Held After
40,702
% of Holdings
3.5%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
80
Price
$533.41
Total Value
$42.67K
Shares Held After
45,172
% of Holdings
0.2%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
650
Price
$532.50
Total Value
$346.12K
Shares Held After
45,252
% of Holdings
1.4%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
794
Price
$531.62
Total Value
$422.11K
Shares Held After
45,902
% of Holdings
1.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
1,776
Price
$530.63
Total Value
$942.41K
Shares Held After
46,696
% of Holdings
3.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
2,808
Price
$529.82
Total Value
$1.49M
Shares Held After
48,472
% of Holdings
5.5%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
1,439
Price
$528.41
Total Value
$760.38K
Shares Held After
51,280
% of Holdings
2.7%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
Mar 19, 2026
Sale
Shares
753
Price
$527.47
Total Value
$397.18K
Shares Held After
52,719
% of Holdings
1.4%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Mar 18, 2026
Sale
Shares
1,814
Price
$198.65
Total Value
$360.36K
Shares Held After
259,255
% of Holdings
0.7%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Mar 18, 2026
Sale
Shares
956
Price
$197.84
Total Value
$189.14K
Shares Held After
261,069
% of Holdings
0.4%

Natera, Inc. (NTRA)

Sheena Jonathan — Director
Mar 18, 2026
Sale
Shares
300
Price
$196.27
Total Value
$58.88K
Shares Held After
262,025
% of Holdings
0.1%
Mar 18, 2026
Sale
Shares
9,725
Price
$25.00
Total Value
$243.12K
Shares Held After
571,725
% of Holdings
1.7%

COLLEGIUM PHARMACEUTICAL, INC (COLL)

Dieter David — EVP & General Counsel
Mar 18, 2026
Sale
Shares
13,976
Price
$34.92
Total Value
$488.10K
Shares Held After
77,071
% of Holdings
15.4%
Mar 18, 2026
Sale
Shares
6,499
Price
$18.84
Total Value
$122.41K
Shares Held After
339,392
% of Holdings
1.9%
Mar 18, 2026
Sale
Shares
31,570
Price
$9.42
Total Value
$297.39K
Shares Held After
1,691,044
% of Holdings
1.8%

Immunovant, Inc. (IMVT)

Van Tuyl Christopher — Chief Legal Officer
Mar 18, 2026
Sale
Shares
2,877
Price
$24.97
Total Value
$71.84K
Shares Held After
147,053
% of Holdings
1.9%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Mar 18, 2026
Sale
Shares
304
Price
$119.08
Total Value
$36.20K
Shares Held After
0
% of Holdings
100.0%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Mar 18, 2026
Sale
Shares
1,730
Price
$118.37
Total Value
$204.78K
Shares Held After
304
% of Holdings
85.1%

PALVELLA THERAPEUTICS, INC. (PVLA)

Goin Kathleen — Chief Operating Officer
Mar 18, 2026
Sale
Shares
2,268
Price
$117.56
Total Value
$266.63K
Shares Held After
2,034
% of Holdings
52.7%

Neuronetics, Inc. (STIM)

Chernett Jorey — 10% Owner
Mar 18, 2026
Purchase
Shares
607,400
Price
$1.35
Total Value
$819.99K
Shares Held After
8,123,804
% of Holdings
7.5%
Mar 18, 2026
Sale
Shares
2,651
Price
$53.64
Total Value
$142.21K
Shares Held After
80,360
% of Holdings
3.2%
Mar 18, 2026
Sale
Shares
3,598
Price
$53.03
Total Value
$190.82K
Shares Held After
83,011
% of Holdings
4.2%
Mar 18, 2026
Sale
Shares
4,311
Price
$51.80
Total Value
$223.30K
Shares Held After
86,609
% of Holdings
4.7%

ARVINAS, INC. (ARVN)

Berkowitz Noah — Chief Medical Officer
Mar 18, 2026
Sale
Shares
6,435
Price
$11.10
Total Value
$71.43K
Shares Held After
202,503
% of Holdings
3.1%

Alignment Healthcare, Inc. (ALHC)

JOYCE CHRISTOPHER J — Chief Legal and Admin. Officer
Mar 18, 2026
Sale
Shares
25,125
Price
$17.84
Total Value
$448.23K
Shares Held After
323,464
% of Holdings
7.2%

Alignment Healthcare, Inc. (ALHC)

Burzacchi Sebastian — COO - Mgmt Services Org
Mar 18, 2026
Sale
Shares
15,361
Price
$17.84
Total Value
$274.04K
Shares Held After
258,630
% of Holdings
5.6%
Mar 18, 2026
Sale
Shares
11,667
Price
$68.71
Total Value
$801.64K
Shares Held After
45,385
% of Holdings
20.4%

Alignment Healthcare, Inc. (ALHC)

Kim Hyong — Chief Medical Officer
Mar 18, 2026
Sale
Shares
18,404
Price
$17.84
Total Value
$328.33K
Shares Held After
367,701
% of Holdings
4.8%
Mar 18, 2026
Sale
Shares
36,749
Price
$17.84
Total Value
$655.60K
Shares Held After
1,058,813
% of Holdings
3.4%
Mar 18, 2026
Sale
Shares
73,046
Price
$17.84
Total Value
$1.30M
Shares Held After
1,784,868
% of Holdings
3.9%
Mar 18, 2026
Purchase
Shares
519,196
Price
$11.15
Total Value
$5.79M
Shares Held After
6,868,820
% of Holdings
7.6%

Tarsus Pharmaceuticals, Inc. (TARS)

Farrow Jeffrey S — Chief Financial Officer and Chief Strategy Officer
Mar 18, 2026
Sale
Shares
2,133
Price
$68.71
Total Value
$146.56K
Shares Held After
45,502
% of Holdings
4.5%

Tarsus Pharmaceuticals, Inc. (TARS)

Neervannan Seshadri — Chief Operating Officer
Mar 18, 2026
Sale
Shares
3,610
Price
$68.71
Total Value
$248.04K
Shares Held After
90,369
% of Holdings
3.8%

Tarsus Pharmaceuticals, Inc. (TARS)

Lin Elizabeth Yeu — Chief Medical Officer
Mar 18, 2026
Sale
Shares
379
Price
$68.71
Total Value
$26.04K
Shares Held After
23,698
% of Holdings
1.6%

Tarsus Pharmaceuticals, Inc. (TARS)

Whitfield Dianne C. — Chief Human Resources Officer
Mar 18, 2026
Sale
Shares
4,071
Price
$68.71
Total Value
$279.72K
Shares Held After
39,202
% of Holdings
9.4%

Tarsus Pharmaceuticals, Inc. (TARS)

Mottiwala Aziz — Chief Commercial Officer
Mar 18, 2026
Sale
Shares
4,330
Price
$68.71
Total Value
$297.51K
Shares Held After
65,920
% of Holdings
6.2%

Tarsus Pharmaceuticals, Inc. (TARS)

Wahl Bryan — General Counsel
Mar 18, 2026
Sale
Shares
4,125
Price
$68.71
Total Value
$283.43K
Shares Held After
68,190
% of Holdings
5.7%

Alignment Healthcare, Inc. (ALHC)

Wagner Andreas P. — Chief Human Resources Officer
Mar 18, 2026
Sale
Shares
12,000
Price
$17.84
Total Value
$214.08K
Shares Held After
160,230
% of Holdings
7.0%

Alignment Healthcare, Inc. (ALHC)

Scavo Robert L. — Chief Information Officer
Mar 18, 2026
Sale
Shares
11,285
Price
$17.84
Total Value
$201.32K
Shares Held After
487,685
% of Holdings
2.3%

Stoke Therapeutics, Inc. (STOK)

Allan Jonathan — GENERAL COUNSEL & CORP SEC
Mar 18, 2026
Sale
Shares
72
Price
$32.85
Total Value
$2.37K
Shares Held After
28,836
% of Holdings
0.2%

Stoke Therapeutics, Inc. (STOK)

Allan Jonathan — GENERAL COUNSEL & CORP SEC
Mar 18, 2026
Sale
Shares
334
Price
$31.79
Total Value
$10.62K
Shares Held After
28,908
% of Holdings
1.1%
Version: v26.3.23